(E)-N'-{7-[1-(2-fluorophenoxy)ethyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}-N,N-dimethylmethanimidamide

Catalog No. :
ACGADQ019
CAS No. :
477865-53-5
Molecular Formula :
C16H17FN6O
Molecular Weight :
328.35

IUPAC Name:(E)-N'-(7-(1-(2-fluorophenoxy)ethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N,N-dimethylformimidamide

(E)-N'-{7-[1-(2-fluorophenoxy)ethyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}-N,N-dimethylmethanimidamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-N'-{7-[1-(2-fluorophenoxy)ethyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}-N,N-dimethylmethanimidamide
IUPAC Name(E)-N'-(7-(1-(2-fluorophenoxy)ethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N,N-dimethylformimidamide
Molecular FormulaC16H17FN6O
Molecular Weight328.35
SMILESCN(C)/C=N/C1=NN2C(C(OC3=CC=CC=C3F)C)=CC=NC2=N1
InChI KeyQMRAMGREYWZEKN-VXLYETTFSA-N
SynonymN'-(7-[1-(2-FLUOROPHENOXY)ETHYL][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2-YL)-N,N-DIMETHYLIMINOFORMAMIDE;(E)-N'-{7-[1-(2-fluorophenoxy)ethyl]-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}-N,N-dimethylmethanimidamide;Methanimidamide, N'-[7-[1-(2-fluorophenoxy)ethyl][1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-N,N-dimethyl-
CAS No.477865-53-5

Synthetic Route by SureRoute

1. ACGADQ019 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGADQ019 route product structure diagram
    ACGADQ019477865-53-5
Inquiry

2. ACGADQ019 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGADQ019 route product structure diagram
    ACGADQ019477865-53-5
Inquiry

Comments (0)